Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Genfit SA (FR:GNFT)
PARIS:GNFT
Holding FR:GNFT?
Track your performance easily
GNFT Stock Chart & Stats
Day’s Range€0 - €0
52-Week Range€2.84 - €5.79
Previous Close€3.93
Volume1.33K
Average Volume (3M)348.32K
Market Cap
€195.60M
Enterprise Value€187.99M
Total Cash (Recent Filing)$77.79M
Total Debt (Recent Filing)$70.18M
Price to Earnings (P/E)―
Beta0.79
Next Earnings
Sep 19, 2024EPS Estimate
€0.31Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.58
Shares Outstanding49,834,983
10 Day Avg. Volume113,269
30 Day Avg. Volume348,324
Standard Deviation0.19
R-Squared0.09
Alpha-0.00726
Financial Highlights & Ratios
Price to Book (P/B)0.38
Price to Sales (P/S)7.54
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit6.58
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€8.40Price Target Upside112.56% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
Options Prices
Currently, No data available
---
Ownership Overview
0.00%
Insiders
0.18% Mutual Funds
0.04% Other Institutional Investors
99.78% Public Companies and
Individual Investors
GNFT FAQ
What was Genfit SA’s price range in the past 12 months?
Genfit SA lowest stock price was €2.84 and its highest was €5.79 in the past 12 months.
What is Genfit SA’s market cap?
Currently, no data Available
When is Genfit SA’s upcoming earnings report date?
Genfit SA’s upcoming earnings report date is Sep 19, 2024 which is in 25 days.
How were Genfit SA’s earnings last quarter?
Genfit SA released its earnings results on Apr 04, 2024. The company reported -€0.16 earnings per share for the quarter, missing the consensus estimate of €0.78 by -€0.94.
Is Genfit SA overvalued?
According to Wall Street analysts Genfit SA’s price is currently Undervalued.
Does Genfit SA pay dividends?
Genfit SA does not currently pay dividends.
What is Genfit SA’s EPS estimate?
Genfit SA’s EPS estimate is €0.31.
How many shares outstanding does Genfit SA have?
Genfit SA has 49,939,040 shares outstanding.
What happened to Genfit SA’s price movement after its last earnings report?
Genfit SA reported an EPS of -€0.16 in its last earnings report, missing expectations of €0.78. Following the earnings report the stock price went down -1.538%.
Which hedge fund is a major shareholder of Genfit SA?
Currently, no hedge funds are holding shares in FR:GNFT
---
Genfit Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
24.71%
12-Months-Change
Fundamentals
Return on Equity
-35.74%
Trailing 12-Months
Asset Growth
-16.55%
Trailing 12-Months
Company Description
Genfit SA
Genfit SA is a biopharmaceutical company involved in drug discovery and development for the early diagnosis, prevention and treatment of cardiometabolic diseases. The company focuses on the discovery and development of drug candidates in areas of high unmet medical needs corresponding to a lack of suitable treatments. It focuses on medicines to market for patients with metabolic, inflammatory, autoimmune and fibrotic diseases, that affect the liver. The company was founded by Jean-François Mouney, Florence Séjourné and Bart Staels on September 1999 and is headquartered in Loos, France.
---
GNFT Earnings Call
Q2 2023
0:00 / 0:00
---
GNFT Stock 12 Month Forecast
Average Price Target
€8.40
▲(112.56% Upside)
Technical Analysis
Best Analysts Covering GNFT
1 Year
1 Year Success Rate
9/12 ratings generated profit
1 Year Average Return
+15.01%
reiterated a buy rating 26 days ago
Copying Justine Telliez's trades and holding each position for 1 Year would result in 75.00% of your transactions generating a profit, with an average return of +15.01% per trade.
---